Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$209.34 - $261.61 $19.9 Million - $24.9 Million
95,011 Added 47.58%
294,700 $69.4 Million
Q3 2022

Nov 14, 2022

SELL
$246.08 - $343.65 $568,690 - $794,175
-2,311 Reduced 1.14%
199,689 $49.1 Million
Q2 2022

Aug 12, 2022

BUY
$280.61 - $420.45 $55.3 Million - $82.9 Million
197,100 Added 4022.45%
202,000 $61.1 Million
Q1 2022

May 13, 2022

BUY
$357.49 - $445.92 $1.18 Million - $1.47 Million
3,300 Added 206.25%
4,900 $2.01 Million
Q4 2021

Feb 11, 2022

BUY
$402.25 - $471.34 $643,600 - $754,144
1,600 New
1,600 $750,000
Q1 2021

May 13, 2021

SELL
$257.29 - $307.53 $11.4 Million - $13.6 Million
-44,200 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$261.16 - $301.66 $11.5 Million - $13.3 Million
44,200 New
44,200 $12.5 Million
Q3 2020

Nov 13, 2020

SELL
$224.99 - $288.02 $13.7 Million - $17.6 Million
-61,100 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$149.8 - $227.17 $45.6 Million - $69.1 Million
-304,100 Reduced 83.27%
61,100 $13.9 Million
Q1 2020

May 14, 2020

SELL
$128.96 - $174.76 $25.2 Million - $34.1 Million
-195,200 Reduced 34.83%
365,200 $55.6 Million
Q4 2019

Feb 13, 2020

BUY
$137.6 - $151.21 $25.8 Million - $28.4 Million
187,700 Added 50.36%
560,400 $84.2 Million
Q3 2019

Nov 13, 2019

BUY
$121.41 - $150.02 $7.73 Million - $9.56 Million
63,700 Added 20.61%
372,700 $52.9 Million
Q2 2019

Aug 12, 2019

SELL
$111.27 - $125.15 $12.4 Million - $14 Million
-111,600 Reduced 26.53%
309,000 $38.7 Million
Q1 2019

May 14, 2019

BUY
$94.53 - $110.2 $26.6 Million - $31 Million
281,000 Added 201.29%
420,600 $46.4 Million
Q4 2018

Feb 13, 2019

BUY
$93.0 - $123.98 $13 Million - $17.3 Million
139,600 New
139,600 $13.7 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.5B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.